本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aura Biosciences, Inc.

7.06
-0.0300-0.42%
盤後7.060.00000.00%17:17 EDT
成交量:28.57萬
成交額:199.61萬
市值:4.53億
市盈率:-4.01
高:7.07
開:7.02
低:6.86
收:7.09
52周最高:7.48
52周最低:4.35
股本:6,415.05萬
流通股本:3,666.37萬
量比:0.95
換手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-1.7599
每股收益(LYR):-1.7599
淨資產收益率:-73.52%
總資產收益率:-40.06%
市淨率:3.31
市盈率(LYR):-4.01

資料載入中...

2024/03/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities